ACCC Capitol Hill Day gives ACCC members the opportunity to meet with members of Congress and their staff to inform them of priority issues affecting access to, and delivery of, cancer care. Members will advocate for legislative and policy changes on issues important to the cancer care community and the patients they serve. It will begin with a training and then small groups of members will go to identified Capitol Hill offices.

To register for this session, click the “Add” button in the registration process.

This event is open only to providers and administrators at health care institutions. Corporate members and industry should not register for Capitol Hill Day."

This educational conference, Clinical Updates from San Diego on Hematologic Malignancies, is a preconference session included in the ACCC 50th Annual Meeting & Cancer Center Business Summit and is designed to equip hematologic malignancy practitioners with practical tools for implementing cutting-edge data into patient care. The event will spotlight the application of state-of-the-art treatment strategies in clinical practice including advancements in CAR T-cell therapy, bispecific agents, and antibody-drug conjugates, as well as optimal management of associated adverse events. Attendees will have the opportunity to engage with renowned experts, gaining insights into managing hematologic malignancies: leukemias, lymphomas, myeloma, MDS, and MPNs. Throughout the meeting, cases from community providers and panel discussions will provide a platform for debate and peer exchange on challenging, real-world clinical situations.

ACCC's Oncology Practice Transformation and Integration Center (OPTIC) presents this interactive, 2.5-hour workshop in constructing, performing, and measuring initiatives at your cancer program that lead to measurable return on investment (ROI) and impact. Join QI experts and walk away with practical tips to perform quality and process improvement projects at your institution in a meaningful way.

To register for this session, click the “Add” button in the registration process.

Seating is limited and granted on a first-come, first-serve basis.

• Transformative AI Can Increase Early Detection, Create Stage Shift, and Generate Growth, Eon Health
• Enhancing Principal and Chronic Care Management: Implementation Study of the Canopy Platform, Canopy
• Large Scale Evaluation of Pulmonary Nodule Workup: A Real-World Study, AstraZeneca
• Provider Partners See Increases in Billable Services with Patient Engagement Ecosystem, PatientPoint
• Community Education and Awareness in CAR-T Treatment of Multiple Myeloma, Bristol-Myers Squibb
• Technology for Substituting Biosimilars to Improve Practice Efficiency and Financial Health, Flatiron
• Transforming Nursing Research with Ovid® Synthesis, Ovid Synthesis
• Using Machine Learning to Accelerate Identification of Incidental Pancreatic Findings, Azra AI
• AstraZeneca Clinical Trial Diversity Initiatives, AstraZeneca
• Improving Guideline-Concordant Biomarker Testing Through Implementation of a Precision Medicine Steward, ACCC

Supported by

Mila Felder, MD, FACEP
Enterprise Vice President, Well-Being for All Teammates
Advocate Health

#AdvocateHealth is leading the way in rebuilding its 150,000+ workforce post-pandemic. Recognizing wellness as an institutional imperative and creating a new C-suite role—Enterprise Vice President, Well-Being for All Teammates—underscores this commitment. The health care system aligned its organizational interventions with the Stanford Model of Professional Fulfillment, tailoring solutions to local needs. This enterprise-wide approach includes a Peer-to-Peer Support program and a Council of Wellbeing, fostering workplace safety and a culture of support. Immediate, targeted education addresses emergent issues, such as the recent national drug shortage. A vision of co-ownership of well-being with clinical and nonclinical teammates drives the ultimate goal: a work environment where everyone thrives.

Narjust Florez, MD
Associate Director, Cancer Care Equity Program
Dana-Farber Cancer Institute

Founded in 2019, this inclusive lab is made up of 42 members ranging from undergraduates to faculty from 12 different countries, most of whom self-identify as women and/or individuals who are under-represented in medicine. This virtual lab meets monthly to discuss projects, grants, and future collaborations. Joint research efforts focus on professional development of the health care workforce; cancer health disparities; diversity equity, and inclusion in medical education; and social justice in medicine, with a focus on cancer clinical outcomes and survivorship experiences of underserved populations. From 2020 to 2023, the Florez Lab has secured nearly 1.5 million in combined research funding to support the development of translational research to mitigate and provide resources to address disparities in oncology and medical education.

Supported by

Facilitator:

Amy D. Smith, FNP-BC
Director
Meredith & Jeannie Ray Cancer Center

Coordination between sites of care can be challenging for providers and patients. Join subject matter experts for an interactive discussion on 3 models of collaborative care:

• A Community and Academic Partnership to Deliver CAR T-Cell Therapy
  • Amy D. Smith, FNP-BC
    Director
    Meredith & Jeannie Ray Cancer Center
  • Keri Halsema, MSN, RN
    Nurse Practitioner, Blood Disorders Center
    University of Colorado Anschutz
• Fox Chase Cancer Center Care Connect: A Collaborative Care Model Between Oncology and Primary Care
  • Kelly Filchner, PhD, RN, OCN, CCRC
    Director, Fox Chase Cancer Center Partners & Fox Chase Cancer Center Care Connect
    Fox Chaser Cancer Center Assistant Professor, Department of Nursing, University of Scranton
• AccessHope: A Virtual Model Connecting Employer Self-Funded Plans and Treating Physicians with NCI Experts 
  • Karina Lee
    Associate Director, U.S. Health & Wellbeing Benefits
    Gilead Sciences, Inc.
  • Harlan Levine, MD
    President, Health Innovation and Policy, City of Hope
    Chair of the Board, AccessHope.
• It Takes a Village: Using Education to Bridge the Gap in CAR T-Cell Therapy
  • Amy Corrao, MSN, NP-C
    Scientific Director US Medical Affairs – Cellular Therapy
    Bristol Myers Squibb

Facilitator:

Douglas Flora, MD, LSSBB
Executive Medical Director, Oncology Services
St. Elizabeth Healthcare

Speakers:

Hala Borno, MD
Founder and Chief Executive Officer
Trial Library

Praduman Jain
CEO & Founder, Vibrent Health
Principal Investigator, NIH All of Us Research Program

Aisha Montgomery, MD, MPH
Scientific Director of Research
Vibrent Health

Sylvia Zhang
Research Partnerships Lead
Trial Library

Bridget Gonzales, CCRC
Head, Educational Programs & Customer Success
Association of Clinical Research Professionals

An interactive discussion on strategic ACCC partnerships and how member programs and practices can get involved:

• The AIM AHEAD project looks to employ artificial intelligence and machine learning to focus on social determinants of health in rural Appalachia that influence higher rates of cancer death in this underserved population.
• The CORe Initiative aims to create a large, nationwide research community of patients with cancer, survivors, their family members, care partners, or others who feel they are at increased risk for cancer. The goal is to collect diverse data to support more equitable cancer-related research and provide greater access to information and research opportunities to community members affected by cancer.
• Trial Library is a public benefit company with a mission to improve health equity by expanding access to cancer precision medicine. Its technology is integrated with technology-enabled navigation to facilitate clinical trial discovery for anyone, anywhere. The partnership includes testing Trial Library’s software and services at select ACCC cancer program member locations.
• The Association of Clinical Research Professionals ( ACRP) has developed a tailored clinical research professional training curriculum.

Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Assistant Vice President
Miami Cancer Institute, Baptist Health South Florida

Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC
Director of Pharmacy, Minnesota Oncology
Assistant Professor of Pharmacy, Mayo Clinic College of Medicine

Thomas Kornfield
Founder and CEO
MAST Health Policy Solutions

Tricia Neuman, ScD
Senior Vice President, Executive Director for Program on Medicare Policy, Senior Advisor to the President
KFF

Alti Rahman, MBA, MHA, CSSBB
Chief Strategy and Innovation Officer
American Oncology Network

Nicole Tapay, JD
Director, Cancer Care Delivery and Health Policy
ACCC

Join a discussion about challenges facing oncology providers in these areas:

• The IRA and other legislation and regulations impactingoncology
• Issues specific to patients enrolled in Medicare Advantage plans
• Prior authorizations
• White and brown bagging practices
• Drug shortages
• Supply chain concerns

Supported by

Facilitator:

Sigrun Hallmeyer, MD
Medical Director, Advocate Lutheran General Hospital Cancer Service Line
Medical Director, Advocate Lutheran General Hospital Cancer Survivorship Center
Co-Director, Medical Research Advocate Aurora Health

Speakers:

Brian Davis
Genomics Implementation Lead
Epic

Christopher McNair, PhD
Associate Director for Data Science, Director of Cancer Informatics, Sidney Kimmel Cancer Center

Assistant Professor, Department of Medical Oncology,
Thomas Jefferson University

Nate Wade, PharmD, MBA, BCOP
Associate Director, Clinical Oncology
Flatiron Health

At last year’s deep dive on precision medicine, participants expressed that one of the biggest barriers for physicians is identifying the right patient for the right testing at the right time. Another common challenge is that most EHRs do not store the results in discrete fields. Instead, molecular testing results come back to providers as PDFs, which must then be scanned into the EHR. To help, providers are looking to EHRs to automate processes, such as implementing automatic notifications or alerts when patients are candidates for specific molecular tests and integrating with testing labs and providers to get results back into the patient’s EHR. Some work has been done in response to these discussions, and we would like to follow up on the progress that has been made, share successes, and review challenges. Let’s continue the discussion and see how providers, testing labs, and EHR developers can overcome these challenges and ensure that precision medicine is accessible for all patients with cancer.

HEALTHC(AI)RE: The Age of Algorithms
Join us to discuss Artificial Intelligence's emerging role in transforming healthcare. We'll examine the technology's current uses, future potential, and inherent implications. Can AI improve medicine without compromising care? Let's explore its promising yet precarious position.

Justin Kelley, RN, Nurse Informaticist
AI Healthcare Technology Expert

The first 12 registrants can attend this table topic. We will notify you if you’ve been waitlisted.

Supported by

Facilitator:

Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC
Manager, OSW Supportive Care
Providence Cancer Institute

Speakers:

Jennifer Bires, MSW, LCSW, OSW-C
Executive Director, Life With Cancer and Patient Experience
Inova Health System

Jessie Dorne, MHS, PA-C
Gynecology Oncology Physician Assistant
Baystate Medical Center

Jay Harness, MD
Chief Medical Officer
Maple Tree Cancer Alliance

Lisa Marquette Porat, MSW, LCSW, FAOSW
U.S. Lead, Patient Advocacy
BeiGene USA

Mandi L. Pratt-Chapman, MA, PhD, Hon-OPN-CG
Associate Center Director
GW Cancer Center

Nicole Tapay, JD
Director, Cancer Care Delivery and Health Policy
ACCC

Comprehensive cancer care encompasses a broad range of services that are commonly referred to as supportive oncology care. The delivery of comprehensive cancer care is essential to person-centered care and has been found to greatly improve quality of life and outcomes. Although supportive oncology care services are recommended in guidelines and required by accreditation bodies, inadequate reimbursement and workforce shortages make it challenging to deliver these services. Join a discussion about the provision and reimbursement landscape for these supportive oncology services:

• Patient navigation
• Sexual health services
• Resources and education tailored to LGBTQ+ patients with cancer
• Exercise oncology
• Cancer and mental health: bridging the gap between industry and community

James Hamrick, MD, MPH
Vice President, Clinical Oncology
Flatiron Health

Amogh Rajan
Vantage Health Technologies

Alti Rahman, MBA, MHA, CSSBB
Chief Strategy and Innovation Officer
American Oncology Network

Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Vice President of Clinical Innovation
American Oncology Network

John Sargent
Founding Partner
BroadReach Group

Stephen V. Speicher, MD MS
Senior Medical Director, Head of Healthcare Quality and Safety
Flatiron Health

Will Shapiro
VP of Data Science
Flatiron Health

• Level Set: What do we mean when we use terms such as language learning, machine learning, predictive analytics or algorithms, process automation, business intelligence, and artificial intelligence. How has oncology been using existing methodologies and how does AI fit into these methodologies?
• Ethical and Safety Concerns: What are the ethics of using AI in oncology? How does oncology put a safety framework around these tools? With acknowledgement that bias is built into this technology and will likely worsen inequities in healthcare, what can oncology professionals do to mitigate this effect and protect patients? While the safety mechanisms are still being defined, how can oncology programs self-police?
• Case Studies: Explore the use of AI/BI technology to improve health equity, strengthen financial performance, and support physicians.
• Evaluating AI/BI Technology Solutions: When researching or meeting with possible vendor partners, what do you need to consider? How do you evaluate the solutions(s)? Which questions do you need to ask? We offer practical advice to help programs and practices effectively manage the overload of technology solutions

Renea Austin-Duffin, MPA
Vice President, Cancer Support and Outreach
Mary Bird Perkins Cancer Center

Gladys Pico-Gleason, BSN, RN
Supervisor of Community Programs, Corewell Health
Healthier Communities, More Life Mas Vida, Corewell Health

Amber Leach
Marketing Director
MMR Group, Inc.

Mary Bird Perkins shares information on the development and implementation of this program, which provides critical education and screening at the workplace, making it easy and convenient for workers to participate. Then hear directly from a corporate partner about the importance of participation, how it has improved corporate culture, and the positive impact it has had on the company and its staff.

Katherine Williams
Supervisor, Oncology Community Programs
Cancer Health, Corewell Health

Corewell Health Cancer Care shares an overview of the development of their Community Programs department, which aims to deliver greater access to cancer prevention and early detection screening. Hear about intentional partnerships with community stakeholders and non-profit organizations to engage in co-creating and facilitating outreach activities in underrepresented and underserved communities. Then hear from a partner in their Healthier Communities team who will share insights into their collaboration with the Cancer Care team through the More Life Más Vida program. This program helps participants understand the status of their current health, assess risk for cancer, diabetes, and cardiovascular disease, and support simple behavior changes to positively impact well-being. Learn more about how these teams utilize the unique role of Community Health Workers to bridge gaps in care and improve follow up.

Nadine J. Barrett, PhD, MA, MS
Professor, Department of Social Science and Public Health Policy, Population Health Sciences
Senior Associate Dean, Equity in Research and Community Engagement
Associate Director, Community Outreach and Engagement, Wake Forest Comprehensive Cancer Center and Levine Cancer Institute
Chief Community Engagement Officer, Atrium Health Cancer Service Line
Associate Director, Community Engagement, Maya Angelou Center for Health Equity, CTSI, Wake Forest School of Medicine and Atrium Health

A Sneak Peek at the 2024-2025 ACCC President’s Theme: Reimagining Community Engagement and Equity in Cancer

Supported by

Facilitator:

Kathleen Reed, MS RN
Director, External Scientific Partnerships
AstraZeneca Global Medical Affairs, Oncology Business Unit

Improving Physician Resilience Through Voice Recognition Software

Kimberly Smith, MPA, FACHE
Vice President
Mount Sinai Health System & Tisch Cancer Institute

Improving Provider Satisfaction and Work Culture Through Implementation of a Quality Improvement Program

Kevin Dryanski, MBA
Director of the Oncology Service Line
Cancer Centers of Colorado at SCL Health St. Mary’s Medical Center

Improving Cancer Care Clinician and Staff Burnout

Jennifer Bickel, MD FAAN FAHS
Chief Wellness Officer, Senior Member
Department of Neuro-oncology, Moffit Cancer Center

Improving Recruitment, Onboarding and Retention with a Menu of Innovative Staffing Solutions

Susanne Tameris, MHA
Senior Director Cancer Services
Anne Arundel Medical Center, Luminis Health

Barry Russo
Chief Executive Officer
The Center for Cancer and Blood Disorders

What does “One Voice, One Message” mean in oncology? It is about community oncology programs coming together to respond to changes in the market, have a common voice, and share best practices to learn from one another. To succeed under alternative payment models, it is imperative for oncology programs to put a voice to concerns or barriers to effective delivery of value-based care, improved efficiency, and shared decision-making. This session will look to identify current barriers and explore innovative solutions, including the use of data analytics, that can be shared with public and private payers as they develop and/or refine new alternative payment models.

Teri Bedard, BA, RT(R)(T), CPC
Executive Director, Client & Corporate Resources
Revenue Cycle Coding Strategies

Al B. Benson, III, MD, FACP, FACCC, FASCO
Professor of Medicine
Robert H. Lurie Comprehensive Cancer Center at Northwestern Medicine

Sheetal Kircher, MD
Associate Professor of Medicine
Robert H. Lurie Comprehensive Cancer Center at Northwestern Medicine

In 2019, ACCC conducted a national survey to gauge capacity and barriers to the delivery of comprehensive cancer care services to inform policy and value-based payment reform. This survey found lack of reimbursement for many critical supportive care services to be a significant barrier. In this session, hear about a program Northwestern is piloting to bill for comprehensive cancer care services through effective use of principal care management codes. Then learn how to effectively utilize existing chronic care management codes and operationalize recently added principal illness and navigation codes to bill for the complex level of care required to treat many patients with cancer.

The 2024 Clinical Research Award, which recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community is being presented to Robert Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center

The 2024 David King Community Clinical Scientist Award, which recognizes individuals who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients is being presented to Christa M. Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, Nurse Practitioner and Assistant Researcher, University of Hawaii Cancer Center

Katherine A. Meese, PhD
Assistant Professor, Department of Health Services Administration
University of Alabama at Birmingham

This is a 2-hour session worth 2.0 in-person education credits awarded if the attendee participates for the full length of time. To receive 2.0 education credits you must also attend the ACHE Leadership Training from 11:00 AM – 12:00 PM

With employee burnout, disengagement, and departure from the field of healthcare, maintaining a healthy and flourishing workforce is one of the grandest challenges facing organizations today. The research on what is driving turnover, burnout and disengagement is not what you might think. This highly interactive seminar translates decades of research into evidence-based strategies to maximize the odds of successfully sustaining a thriving workforce.

Katherine A. Meese, PhD
Assistant Professor, Department of Health Services Administration
University of Alabama at Birmingham

This is a 2-hour session worth 2.0 in-person education credits awarded if the attendee participates for the full length of time. To receive 2.0 education credits you must also attend the ACHE Leadership Keynote from 9:30 AM – 10:30 AM

Continue the conversation by exploring elements that support human flourishing, organizational and team strategies to optimize recruitment and retention, the role of job crafting and empowering leadership in engaging the workforce, and evidence-based strategies for improving individual and organizational resilience.

To register, simply click the link below, log in to your existing account, or create a new one, and proceed with the registration process.

Al B. Benson, III, MD, FACP, FACCC, FASCO
Professor of Medicine, Associate Director for Cooperative Groups
Robert H. Lurie Comprehensive Cancer Center at Northwestern Medicine

Josephine Louella Feliciano, MD
Medical Director, Thoracic Oncology Program
Co-director of the Outpatient Oncology Clinic
Johns Hopkins Bayview Medical Center

Julia Trosman, PhD, MBA
Director, Center for Business Models in Healthcare
Assistant Adjunct Professor, Northwestern University Feinberg School of Medicine
Assistant Adjunct Professor, University of California, San Francisco

4R Care Sequences® are guideline-based care plans designed to ensure equitable delivery of quality care. Join us to hear how other programs have benefited from using 4R Care Sequences and learn how your program can access these resources for providers and patients at no cost.